Tvardi Therapeutics Inc.
Organization details
- Legal name
- Tvardi Therapeutics Inc.
- Former names
- Cara Therapeutics, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Sugar Land
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TVRD
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001346830
Board of directors
-
Christopher Posner · Director · PRESIDENT AND CEOSince 2023
- Since 2025
-
Harrison M. Bains Jr. · DirectorSince 2023
-
Helen M. Boudreau · DirectorSince 2023
-
Imran Nizamudin Alibhai · Director · Chief Executive OfficerSince 2025
-
Jeffrey L. Ives · DirectorSince 2023
-
Martin Vogelbaum · DirectorSince 2023
-
Michael S. Wyzga · DirectorSince 2025
-
Moltke Lisa Von · DirectorSince 2023
-
Shaheen Wirk · DirectorSince 2025
-
Sujal Shah · DirectorSince 2025
-
Susan Shiff Ph.D. · DirectorSince 2023
-
Wallace L. Hall Jr. · DirectorSince 2025
Chief executives
Director election results
Annual meeting of June 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
92.7%
-
95.8%
-
96.0%
Board connections
5 of this board's directors also sit on 11 other boards. 10 are in the same sector.
-
Acumen Pharmaceuticals Inc. Same sectorvia Jeffrey L. Ives
-
Agios Pharmaceuticals Inc. Same sectorvia Cynthia Smith
-
Akebia Therapeutics Inc. Same sectorvia Cynthia Smith
- via Shaheen Wirk
-
Invivyd Inc. Same sectorvia Michael S. Wyzga
-
Mereo BioPharma Group plc Same sectorvia Michael S. Wyzga
-
Protara Therapeutics Inc. Same sectorvia Cynthia Smith
-
Rallybio Corporation Same sectorvia Helen M. Boudreau
-
Shattuck Labs Inc. Same sectorvia Helen M. Boudreau
-
Spero Therapeutics Inc. Same sectorvia Cynthia Smith
-
X4 Pharmaceuticals Inc. Same sectorvia Michael S. Wyzga
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 7, 2025 | Tweardy Samuel David 10% owner | Other | −315,658 | — | — |
| Jul 7, 2025 | Tweardy Samuel David 10% owner | Other | −315,658 | — | — |
| Apr 15, 2025 | Wallace L. Hall Jr. Director | Other | +44,712 | — | — |
| Apr 15, 2025 | Shaheen Wirk Director | Grant or award | +4,191 | — | — |
| Apr 15, 2025 | Wallace L. Hall Jr. Director | Other | +202,044 | — | — |
| Apr 15, 2025 | Shaheen Wirk Director | Other | +176,030 | — | — |
| Apr 15, 2025 | Shaheen Wirk Director | Other | +263,164 | — | — |
| Feb 28, 2025 | Christopher Posner Director, Officer (PRESIDENT AND CEO) | Open-market sale | −583 | $4.75 | $2,769 |
| Feb 28, 2025 | Terrillion Scott Officer (SEC'Y; CHIEF COMPLIANCE & G.C.) | Open-market sale | −163 | $4.76 | $776 |
| Feb 4, 2025 | Christopher Posner Director, Officer (PRESIDENT AND CEO) | Open-market sale | −372 | $4.72 | $1,756 |
| Nov 4, 2024 | Christopher Posner Director, Officer (PRESIDENT AND CEO) | Open-market sale | −3,668 | $0.29 | $1,064 |
| Aug 1, 2024 | Christopher Posner Director, Officer (PRESIDENT AND CEO) | Open-market sale | −4,149 | $0.35 | $1,452 |
| Jun 4, 2024 | Helen M. Boudreau Director | Grant or award | +150,647 | — | — |
| Jun 4, 2024 | Moltke Lisa Von Director | Grant or award | +150,647 | — | — |
| Jun 4, 2024 | Jeffrey L. Ives Director | Grant or award | +150,647 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Tvardi Therapeutics Inc.
Who is the CEO of Tvardi Therapeutics Inc.?
Imran Nizamudin Alibhai has been Tvardi Therapeutics Inc.'s Chief Executive Officer since April 2025.
How many directors are on Tvardi Therapeutics Inc.'s board?
Tvardi Therapeutics Inc.'s board has 13 directors: Christopher Posner, Cynthia Smith, Harrison M. Bains Jr., Helen M. Boudreau, Imran Nizamudin Alibhai, Jeffrey L. Ives, Martin Vogelbaum, Michael S. Wyzga, Moltke Lisa Von, Shaheen Wirk and 3 others.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="tvardi-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.